News

(Bloomberg) -- European stocks tumbled into a correction on Friday as China retaliated against US tariffs, escalating the global trade war.Most Read from BloombergHousing Agency Aims to Relocate Its DC HeadquartersMetro-North Is Faster Than Acela on NYC-New Haven Route After Signal UpdatesLocal Governments Vie for Fired Federal WorkersWhat Would ‘Transportation Abundance’ Look Like?London Clears Final Hurdle for More High-Speed Trains to EuropeThe Stoxx Europe 600 Index slid 5.1% at the close in

Mining stocks tumbled Friday amid worries the Trump administration’s tariffs could impact demand for raw materials.

U.S. equities plunged again on trade war fears as China retaliated against U.S. tariffs.

The decision would complicate an uneven recovery for the U.S. IPO market, as the company's listing was seen as a potential catalyst for encouraging others to follow. Klarna could reassess its plans if market conditions stabilize, the people said. While hopes of a recovery were high in 2025, some of the new entrants to the IPO market have seen muted receptions.

(Bloomberg) -- Coffee futures fell for a third day as the market digested a wave of US tariffs against the world’s top producers.Most Read from BloombergHousing Agency Aims to Relocate Its DC HeadquartersMetro-North Is Faster Than Acela on NYC-New Haven Route After Signal UpdatesLocal Governments Vie for Fired Federal WorkersWhat Would ‘Transportation Abundance’ Look Like?London Clears Final Hurdle for More High-Speed Trains to EuropePrices have slumped, following the broader commodity index low

US stock futures slipped after President Trump's broad reciprocal tariffs sent markets into a tailspin.

Some studies of Sarepta Therapeutics' muscular dystrophy drug, Elevidys, have been halted by European regulators after a patient taking it died.